Cargando…
Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway
BACKGROUND: Drug resistance is common in cancer chemotherapy. This study investigates the role of Glycerol kinase 5 (GK5) in mediating gefitinib resistance in NSCLC. METHODS: The exosomal mRNA of GK5 was detected using a tethered cationic lipoplex nanoparticle (TCLN) biochip. Real-time PCR and Weste...
Autores principales: | Zhou, Jian, Qu, Guimei, Zhang, Ge, Wu, Zuoren, Liu, Jing, Yang, Dawei, Li, Jing, Chang, Meijia, Zeng, Hengshan, Hu, Jie, Fang, Tao, Song, Yuanlin, Bai, Chunxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385389/ https://www.ncbi.nlm.nih.gov/pubmed/30791926 http://dx.doi.org/10.1186/s13046-019-1057-7 |
Ejemplares similares
-
Calpain 2 knockdown promotes cell apoptosis and restores gefitinib sensitivity through epidermal growth factor receptor/protein kinase B/survivin signaling
por: Zhang, Ge, et al.
Publicado: (2018) -
Knockdown of PLAT enhances the anticancer effect of gefitinib in non-small cell lung cancer
por: Yan, Mengnan, et al.
Publicado: (2020) -
Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest
por: Zhou, Jian, et al.
Publicado: (2018) -
Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer
por: Xu, Chuncao, et al.
Publicado: (2021) -
Adaptive Changes of the Insig1/SREBP1/SCD1 Set Point Help Adipose Tissue to Cope With Increased Storage Demands of Obesity
por: Carobbio, Stefania, et al.
Publicado: (2013)